Xencor, Inc. (XNCR)
NASDAQ: XNCR · Real-Time Price · USD
12.09
-0.29 (-2.34%)
At close: Jan 30, 2026, 4:00 PM EST
12.09
0.00 (0.00%)
After-hours: Jan 30, 2026, 4:10 PM EST
Xencor Market Cap
Xencor has a market cap or net worth of $863.35 million as of January 30, 2026. Its market cap has decreased by -35.45% in one year.
Market Cap
863.35M
Enterprise Value
347.56M
1-Year Change
-35.45%
Ranking
Category
Stock Price
$12.09
Market Cap Chart
Since December 3, 2013, Xencor's market cap has increased from $245.40M to $863.35M, an increase of 251.81%. That is a compound annual growth rate of 10.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2026 | 884.10M | -19.13% |
| Dec 31, 2025 | 1.09B | -32.02% |
| Dec 31, 2024 | 1.61B | 24.44% |
| Dec 29, 2023 | 1.29B | -17.18% |
| Dec 30, 2022 | 1.56B | -33.50% |
| Dec 31, 2021 | 2.35B | -6.40% |
| Dec 31, 2020 | 2.51B | 28.51% |
| Dec 31, 2019 | 1.95B | -4.07% |
| Dec 31, 2018 | 2.03B | 97.53% |
| Dec 29, 2017 | 1.03B | -4.93% |
| Dec 30, 2016 | 1.08B | 82.97% |
| Dec 31, 2015 | 591.80M | 17.51% |
| Dec 31, 2014 | 503.60M | 87.28% |
| Dec 31, 2013 | 268.90M | 9.58% |
| Dec 3, 2013 | 245.40M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 937.56M |
| ArriVent BioPharma | 931.72M |
| Palvella Therapeutics | 931.65M |
| Bicara Therapeutics | 908.83M |
| Maravai LifeSciences Holdings | 874.52M |
| YD Bio | 860.71M |
| Geron | 849.01M |
| Janux Therapeutics | 839.06M |